Honore Tage 4
4 · Vanda Pharmaceuticals Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Honore Tage
Director
Transactions
- Award
Common Stock
2023-03-15+26,408→ 26,408 total - Award
Stock Option (right to buy)
2023-03-15+51,276→ 51,276 totalExercise: $6.39Exp: 2033-03-14→ Common Stock (51,276 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 15, 2024, provided the Reporting Person has provided continuous service through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- [F2]The option vests with respect to 25% of the underlying shares on March 15, 2024, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.